-
-
-
-
-
-
-
Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
-
-
-
-
-
-
-
Rocket Pharmaceuticals (RCKT) Announces FDA Acceptance of BLA with Priority Review for RP-L201 for Treatment of Severe Leukocyte Adhesion Deficiency-I
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

